OVERVIEW

Advancements in Cancer Management: Management of Lung and Thyroid Lesions is organized by Cancer Treatment Centers of America® (CTCA).

Time: October 7, 2020 4:00 - 5:30 pm ET (US and Canada)

Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Morehouse School of Medicine and Cancer Treatment Centers of America®. The Morehouse School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Osteopathic Founders Foundation is accredited by the American Osteopathic Association to provide osteopathic continuing medical education.

Credit Designation:
The Morehouse School of Medicine designates this live activity for AMA PRA Category 1 CreditsTM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

The Osteopathic Founders Foundation designates this live interactive online program for AOA Category 1-A credits, and will report CME and specialty credits for all physicians who complete the online evaluation and self-attestation form. Credit claimed should be commensurate with the physician's participation in the program.

Description:
The 5th annual Advancements in Cancer Management is an educational series designed to foster dialog between primary care providers (PCPs) and the oncology team, providing strategies that contribute to coordinated, multi-disciplinary care for patients with cancer.

In this episode of the series, Daniel Miller, MD, will discuss the management of lung lesions and Craig Richman, MD, FACS, will discuss thyroid lesions, highlighting the latest research, recommendations and guidelines, for primary care providers.

After participating in this education, learners will be able to:
• Discuss the diagnosis and management of lung lesions
• Discuss the diagnosis and management of thyroid lesions